|
Code
|
System
|
Display
|
English
(English,
en)
Display
(English)
|
54
01
|
http://hl7.org/fhir/sid/cvx
|
adenovirus
vaccine,
type
4,
live,
oral
DTP
|
adenovirus,
type
4
diphtheria,
tetanus
toxoids
and
pertussis
vaccine
|
55
02
|
http://hl7.org/fhir/sid/cvx
|
adenovirus
OPV
|
trivalent
poliovirus
vaccine,
type
7,
live,
oral
|
adenovirus,
type
7
82
03
|
http://hl7.org/fhir/sid/cvx
|
adenovirus
vaccine,
unspecified
formulation
MMR
|
adenovirus,
unspecified
formulation
measles,
mumps
and
rubella
virus
vaccine
|
24
04
|
http://hl7.org/fhir/sid/cvx
|
anthrax
vaccine
M/R
|
anthrax
measles
and
rubella
virus
vaccine
|
19
05
|
http://hl7.org/fhir/sid/cvx
|
Bacillus
Calmette-Guerin
vaccine
measles
|
BCG
measles
virus
vaccine
|
27
06
|
http://hl7.org/fhir/sid/cvx
|
botulinum
antitoxin
rubella
|
rubella
virus
vaccine
|
26
07
|
http://hl7.org/fhir/sid/cvx
|
cholera
vaccine,
unspecified
formulation
mumps
|
cholera,
unspecified
formulation
mumps
virus
vaccine
|
29
08
|
http://hl7.org/fhir/sid/cvx
|
cytomegalovirus
immune
globulin,
intravenous
Hep
B,
adolescent
or
pediatric
|
CMVIG
hepatitis
B
vaccine,
pediatric
or
pediatric/adolescent
dosage
|
56
09
|
http://hl7.org/fhir/sid/cvx
|
dengue
fever
vaccine
Td
(adult),
2
Lf
tetanus
toxoid,
preservative
free,
adsorbed
|
dengue
fever
tetanus
and
diphtheria
toxoids,
adsorbed,
preservative
free,
for
adult
use
(2
Lf
of
tetanus
toxoid
and
2
Lf
of
diphtheria
toxoid)
|
12
10
|
http://hl7.org/fhir/sid/cvx
|
diphtheria
antitoxin
IPV
|
poliovirus
vaccine,
inactivated
|
28
11
|
http://hl7.org/fhir/sid/cvx
|
diphtheria
and
tetanus
toxoids,
adsorbed
for
pediatric
use
pertussis
|
DT
(pediatric)
pertussis
vaccine
|
20
12
|
http://hl7.org/fhir/sid/cvx
|
diphtheria,
tetanus
toxoids
and
acellular
pertussis
vaccine
diphtheria
antitoxin
|
DTaP
diphtheria
antitoxin
|
106
13
|
http://hl7.org/fhir/sid/cvx
|
diphtheria,
tetanus
toxoids
and
acellular
pertussis
vaccine,
5
pertussis
antigens
TIG
|
DTaP,
5
pertussis
antigens
tetanus
immune
globulin
|
107
14
|
http://hl7.org/fhir/sid/cvx
|
diphtheria,
tetanus
toxoids
and
acellular
pertussis
vaccine,
IG,
unspecified
formulation
|
DTaP,
immune
globulin,
unspecified
formulation
|
110
15
|
http://hl7.org/fhir/sid/cvx
|
DTaP-hepatitis
B
and
poliovirus
vaccine
influenza,
split
(incl.
purified
surface
antigen)
|
DTaP-Hep
B-IPV
influenza
virus
vaccine,
split
virus
(incl.
purified
surface
antigen)-retired
CODE
|
50
16
|
http://hl7.org/fhir/sid/cvx
|
DTaP-Haemophilus
influenzae
type
b
conjugate
vaccine
influenza,
whole
|
DTaP-Hib
influenza
virus
vaccine,
whole
virus
|
120
17
|
http://hl7.org/fhir/sid/cvx
|
diphtheria,
tetanus
toxoids
and
acellular
pertussis
vaccine,
Hib,
unspecified
formulation
|
Haemophilus
influenzae
type
b
conjugate,
and
poliovirus
vaccine,
inactivated
(DTaP-Hib-IPV)
conjugate
unspecified
formulation
|
|
18
|
DTaP-Hib-IPV
http://hl7.org/fhir/sid/cvx
|
rabies,
intramuscular
injection
|
rabies
vaccine,
for
intramuscular
injection
RETIRED
CODE
|
130
19
|
http://hl7.org/fhir/sid/cvx
|
Diphtheria,
tetanus
toxoids
and
acellular
pertussis
vaccine,
and
poliovirus
vaccine,
inactivated
BCG
|
DTaP-IPV
Bacillus
Calmette-Guerin
vaccine
|
01
20
|
http://hl7.org/fhir/sid/cvx
|
DTaP
|
diphtheria,
tetanus
toxoids
and
acellular
pertussis
vaccine
|
DTP
22
21
|
http://hl7.org/fhir/sid/cvx
|
DTP-Haemophilus
influenzae
type
b
conjugate
vaccine
varicella
|
DTP-Hib
varicella
virus
vaccine
|
102
22
|
http://hl7.org/fhir/sid/cvx
|
DTP-
Haemophilus
DTP-Hib
|
DTP-Haemophilus
influenzae
type
b
conjugate
and
hepatitis
b
vaccine
|
DTP-Hib-Hep
B
57
23
|
http://hl7.org/fhir/sid/cvx
|
hantavirus
vaccine
plague
|
hantavirus
plague
vaccine
|
52
24
|
http://hl7.org/fhir/sid/cvx
|
hepatitis
A
vaccine,
adult
dosage
anthrax
|
Hep
A,
adult
anthrax
vaccine
|
83
25
|
http://hl7.org/fhir/sid/cvx
|
hepatitis
A
vaccine,
pediatric/adolescent
dosage,
2
dose
schedule
typhoid,
oral
|
Hep
A,
ped/adol,
2
dose
typhoid
vaccine,
live,
oral
|
84
26
|
http://hl7.org/fhir/sid/cvx
|
hepatitis
A
vaccine,
pediatric/adolescent
dosage,
3
dose
schedule
cholera,
unspecified
formulation
|
Hep
A,
ped/adol,
3
dose
cholera
vaccine,
unspecified
formulation
|
31
27
|
http://hl7.org/fhir/sid/cvx
|
hepatitis
A
vaccine,
pediatric
dosage,
unspecified
formulation
botulinum
antitoxin
|
Hep
A,
pediatric,
unspecified
formulation
botulinum
antitoxin
|
85
28
|
http://hl7.org/fhir/sid/cvx
|
hepatitis
A
vaccine,
unspecified
formulation
DT
(pediatric)
|
Hep
A,
unspecified
formulation
diphtheria
and
tetanus
toxoids,
adsorbed
for
pediatric
use
|
104
29
|
http://hl7.org/fhir/sid/cvx
|
hepatitis
A
and
hepatitis
B
vaccine
CMVIG
|
Hep
A-Hep
B
cytomegalovirus
immune
globulin,
intravenous
|
|
30
|
http://hl7.org/fhir/sid/cvx
|
HBIG
|
hepatitis
B
immune
globulin
|
HBIG
08
31
|
http://hl7.org/fhir/sid/cvx
|
hepatitis
B
vaccine,
pediatric
or
pediatric/adolescent
dosage
Hep
A,
pediatric,
unspecified
formulation
|
Hep
B,
adolescent
or
hepatitis
A
vaccine,
pediatric
dosage,
unspecified
formulation
|
42
32
|
http://hl7.org/fhir/sid/cvx
|
hepatitis
B
vaccine,
adolescent/high
risk
infant
dosage
meningococcal
MPSV4
|
Hep
B,
adolescent/high
risk
infant
meningococcal
polysaccharide
vaccine
(MPSV4)
|
43
33
|
http://hl7.org/fhir/sid/cvx
|
hepatitis
B
vaccine,
adult
dosage
pneumococcal
polysaccharide
PPV23
|
Hep
B,
adult
pneumococcal
polysaccharide
vaccine,
23
valent
|
44
34
|
http://hl7.org/fhir/sid/cvx
|
hepatitis
B
vaccine,
dialysis
patient
dosage
RIG
|
Hep
B,
dialysis
rabies
immune
globulin
|
45
35
|
http://hl7.org/fhir/sid/cvx
|
hepatitis
B
vaccine,
unspecified
formulation
tetanus
toxoid,
adsorbed
|
Hep
B,
unspecified
formulation
tetanus
toxoid,
adsorbed
|
58
36
|
http://hl7.org/fhir/sid/cvx
|
hepatitis
C
vaccine
VZIG
|
Hep
C
varicella
zoster
immune
globulin
|
59
37
|
http://hl7.org/fhir/sid/cvx
|
hepatitis
E
vaccine
yellow
fever
|
Hep
E
yellow
fever
vaccine
|
60
38
|
http://hl7.org/fhir/sid/cvx
|
herpes
simplex
virus,
type
2
vaccine
rubella/mumps
|
herpes
simplex
2
rubella
and
mumps
virus
vaccine
|
46
39
|
http://hl7.org/fhir/sid/cvx
|
Haemophilus
influenzae
type
b
vaccine,
PRP-D
conjugate
Japanese
encephalitis
SC
|
Hib
(PRP-D)
Japanese
Encephalitis
Vaccine
SC
|
47
40
|
http://hl7.org/fhir/sid/cvx
|
Haemophilus
influenzae
type
b
vaccine,
HbOC
conjugate
rabies,
intradermal
injection
|
Hib
(HbOC)
rabies
vaccine,
for
intradermal
injection
|
48
41
|
http://hl7.org/fhir/sid/cvx
|
Haemophilus
influenzae
type
b
vaccine,
PRP-T
conjugate
typhoid,
parenteral
|
Hib
(PRP-T)
typhoid
vaccine,
parenteral,
other
than
acetone-killed,
dried
|
49
42
|
http://hl7.org/fhir/sid/cvx
|
Haemophilus
influenzae
type
b
vaccine,
PRP-OMP
conjugate
Hep
B,
adolescent/high
risk
infant
|
Hib
(PRP-OMP)
hepatitis
B
vaccine,
adolescent/high
risk
infant
dosage
|
17
43
|
http://hl7.org/fhir/sid/cvx
|
Haemophilus
influenzae
type
b
vaccine,
conjugate
unspecified
formulation
Hep
B,
adult
|
Hib,
unspecified
formulation
hepatitis
B
vaccine,
adult
dosage
|
51
44
|
http://hl7.org/fhir/sid/cvx
|
Haemophilus
influenzae
type
b
conjugate
and
Hepatitis
B
vaccine
Hep
B,
dialysis
|
Hib-Hep
hepatitis
B
vaccine,
dialysis
patient
dosage
|
61
45
|
http://hl7.org/fhir/sid/cvx
|
human
immunodeficiency
virus
vaccine
Hep
B,
unspecified
formulation
|
HIV
hepatitis
B
vaccine,
unspecified
formulation
|
118
46
|
http://hl7.org/fhir/sid/cvx
|
human
papilloma
virus
vaccine,
bivalent
Hib
(PRP-D)
|
HPV,
bivalent
Haemophilus
influenzae
type
b
vaccine,
PRP-D
conjugate
|
62
47
|
http://hl7.org/fhir/sid/cvx
|
human
papilloma
virus
vaccine,
quadrivalent
Hib
(HbOC)
|
HPV,
quadrivalent
Haemophilus
influenzae
type
b
vaccine,
HbOC
conjugate
|
86
48
|
http://hl7.org/fhir/sid/cvx
|
immune
globulin,
intramuscular
Hib
(PRP-T)
|
IG
Haemophilus
influenzae
type
b
vaccine,
PRP-T
conjugate
|
87
49
|
http://hl7.org/fhir/sid/cvx
|
immune
globulin,
intravenous
Hib
(PRP-OMP)
|
IGIV
Haemophilus
influenzae
type
b
vaccine,
PRP-OMP
conjugate
|
14
50
|
http://hl7.org/fhir/sid/cvx
|
immune
globulin,
unspecified
formulation
DTaP-Hib
|
IG,
unspecified
formulation
DTaP-Haemophilus
influenzae
type
b
conjugate
vaccine
|
111
51
|
http://hl7.org/fhir/sid/cvx
|
influenza
virus
vaccine,
live,
attenuated,
for
intranasal
use
Hib-Hep
B
|
influenza,
live,
intranasal
Haemophilus
influenzae
type
b
conjugate
and
Hepatitis
B
vaccine
|
15
52
|
http://hl7.org/fhir/sid/cvx
|
influenza
virus
vaccine,
split
virus
(incl.
purified
surface
antigen)-retired
CODE
Hep
A,
adult
|
influenza,
split
(incl.
purified
surface
antigen)
hepatitis
A
vaccine,
adult
dosage
|
16
53
|
http://hl7.org/fhir/sid/cvx
|
influenza
virus
vaccine,
whole
virus
typhoid,
parenteral,
AKD
(U.S.
military)
|
influenza,
whole
typhoid
vaccine,
parenteral,
acetone-killed,
dried
(U.S.
military)
|
88
54
|
http://hl7.org/fhir/sid/cvx
|
influenza
virus
vaccine,
unspecified
formulation
adenovirus,
type
4
|
influenza,
unspecified
formulation
adenovirus
vaccine,
type
4,
live,
oral
|
123
55
|
http://hl7.org/fhir/sid/cvx
|
influenza
virus
vaccine,
H5N1,
A/Vietnam/1203/2004
(national
stockpile)
adenovirus,
type
7
|
influenza,
H5N1-1203
adenovirus
vaccine,
type
7,
live,
oral
|
10
56
|
http://hl7.org/fhir/sid/cvx
|
poliovirus
vaccine,
inactivated
dengue
fever
tetravalent
|
IPV
dengue
fever
vaccine,
tetravalent
|
02
57
|
http://hl7.org/fhir/sid/cvx
|
trivalent
poliovirus
vaccine,
live,
oral
hantavirus
|
OPV
hantavirus
vaccine
|
89
58
|
http://hl7.org/fhir/sid/cvx
|
poliovirus
vaccine,
unspecified
formulation
Hep
C
|
polio,
unspecified
formulation
hepatitis
C
vaccine
|
39
59
|
http://hl7.org/fhir/sid/cvx
|
Japanese
Encephalitis
Vaccine
SC
Hep
E
|
Japanese
encephalitis
SC
hepatitis
E
vaccine
|
63
60
|
http://hl7.org/fhir/sid/cvx
|
Junin
virus
vaccine
herpes
simplex
2
|
Junin
virus
herpes
simplex
virus,
type
2
vaccine
|
64
61
|
http://hl7.org/fhir/sid/cvx
|
leishmaniasis
vaccine
HIV
|
leishmaniasis
human
immunodeficiency
virus
vaccine
|
65
62
|
http://hl7.org/fhir/sid/cvx
|
leprosy
vaccine
HPV,
quadrivalent
|
leprosy
human
papilloma
virus
vaccine,
quadrivalent
|
66
63
|
http://hl7.org/fhir/sid/cvx
|
Lyme
disease
vaccine
Junin
virus
|
Lyme
disease
Junin
virus
vaccine
|
03
64
|
http://hl7.org/fhir/sid/cvx
|
measles,
mumps
and
rubella
virus
vaccine
leishmaniasis
|
MMR
leishmaniasis
vaccine
|
04
65
|
http://hl7.org/fhir/sid/cvx
|
measles
and
rubella
virus
vaccine
leprosy
|
M/R
leprosy
vaccine
|
94
66
|
http://hl7.org/fhir/sid/cvx
|
measles,
mumps,
rubella,
and
varicella
virus
vaccine
Lyme
disease
|
MMRV
Lyme
disease
vaccine
|
|
67
|
http://hl7.org/fhir/sid/cvx
|
malaria
vaccine
|
malaria
vaccine
|
05
68
|
http://hl7.org/fhir/sid/cvx
|
measles
virus
vaccine
melanoma
|
measles
melanoma
vaccine
|
68
69
|
http://hl7.org/fhir/sid/cvx
|
melanoma
vaccine
parainfluenza-3
|
melanoma
parainfluenza-3
virus
vaccine
|
32
70
|
http://hl7.org/fhir/sid/cvx
|
meningococcal
polysaccharide
vaccine
(MPSV4)
Q
fever
|
meningococcal
MPSV4
Q
fever
vaccine
|
103
71
|
http://hl7.org/fhir/sid/cvx
|
meningococcal
C
conjugate
vaccine
RSV-IGIV
|
meningococcal
C
conjugate
respiratory
syncytial
virus
immune
globulin,
intravenous
|
114
72
|
http://hl7.org/fhir/sid/cvx
|
meningococcal
polysaccharide
(groups
A,
C,
Y
and
W-135)
diphtheria
toxoid
conjugate
vaccine
(MCV4P)
rheumatic
fever
|
meningococcal
MCV4P
rheumatic
fever
vaccine
|
108
73
|
http://hl7.org/fhir/sid/cvx
|
meningococcal
ACWY
vaccine,
unspecified
formulation
Rift
Valley
fever
|
meningococcal
ACWY,
unspecified
formulation
Rift
Valley
fever
vaccine
|
07
74
|
http://hl7.org/fhir/sid/cvx
|
mumps
virus
vaccine
rotavirus,
tetravalent
|
mumps
rotavirus,
live,
tetravalent
vaccine
|
69
75
|
http://hl7.org/fhir/sid/cvx
|
parainfluenza-3
virus
vaccine
vaccinia
(smallpox)
|
parainfluenza-3
vaccinia
(smallpox)
vaccine
|
11
76
|
http://hl7.org/fhir/sid/cvx
|
pertussis
vaccine
Staphylococcus
bacterio
lysate
|
pertussis
Staphylococcus
bacteriophage
lysate
|
23
77
|
http://hl7.org/fhir/sid/cvx
|
plague
Tick-borne
encephalitis
vaccine
(non-US)
|
plague
Tick-borne
encephalitis
vaccine
(non-US)
|
33
78
|
http://hl7.org/fhir/sid/cvx
|
pneumococcal
polysaccharide
vaccine,
23
valent
tularemia
vaccine
|
pneumococcal
polysaccharide
PPV23
tularemia
vaccine
|
100
79
|
http://hl7.org/fhir/sid/cvx
|
pneumococcal
conjugate
vaccine,
7
valent
vaccinia
immune
globulin
|
pneumococcal
conjugate
PCV
7
vaccinia
immune
globulin
|
109
80
|
http://hl7.org/fhir/sid/cvx
|
pneumococcal
vaccine,
unspecified
formulation
VEE,
live
|
pneumococcal,
unspecified
formulation
Venezuelan
equine
encephalitis,
live,
attenuated
|
70
81
|
http://hl7.org/fhir/sid/cvx
|
Q
fever
vaccine
VEE,
inactivated
|
Q
fever
Venezuelan
equine
encephalitis,
inactivated
|
18
82
|
http://hl7.org/fhir/sid/cvx
|
rabies
vaccine,
for
intramuscular
injection
RETIRED
CODE
adenovirus,
unspecified
formulation
|
rabies,
intramuscular
injection
adenovirus
vaccine,
unspecified
formulation
|
40
83
|
http://hl7.org/fhir/sid/cvx
|
rabies
vaccine,
for
intradermal
injection
Hep
A,
ped/adol,
2
dose
|
rabies,
intradermal
injection
hepatitis
A
vaccine,
pediatric/adolescent
dosage,
2
dose
schedule
|
90
84
|
http://hl7.org/fhir/sid/cvx
|
rabies
vaccine,
unspecified
formulation
Hep
A,
ped/adol,
3
dose
|
rabies,
unspecified
formulation
hepatitis
A
vaccine,
pediatric/adolescent
dosage,
3
dose
schedule
|
72
85
|
http://hl7.org/fhir/sid/cvx
|
rheumatic
fever
vaccine
Hep
A,
unspecified
formulation
|
rheumatic
fever
hepatitis
A
vaccine,
unspecified
formulation
|
73
86
|
http://hl7.org/fhir/sid/cvx
|
Rift
Valley
fever
vaccine
IG
|
Rift
Valley
fever
immune
globulin,
intramuscular
|
34
87
|
http://hl7.org/fhir/sid/cvx
|
rabies
immune
globulin
IGIV
|
RIG
immune
globulin,
intravenous
|
119
88
|
http://hl7.org/fhir/sid/cvx
|
rotavirus,
live,
monovalent
vaccine
influenza,
unspecified
formulation
|
rotavirus,
monovalent
influenza
virus
vaccine,
unspecified
formulation
|
122
89
|
http://hl7.org/fhir/sid/cvx
|
rotavirus
vaccine,
polio,
unspecified
formulation
|
rotavirus,
poliovirus
vaccine,
unspecified
formulation
|
116
90
|
http://hl7.org/fhir/sid/cvx
|
rotavirus,
live,
pentavalent
vaccine
rabies,
unspecified
formulation
|
rotavirus,
pentavalent
rabies
vaccine,
unspecified
formulation
|
74
91
|
http://hl7.org/fhir/sid/cvx
|
rotavirus,
live,
tetravalent
vaccine
typhoid,
unspecified
formulation
|
rotavirus,
tetravalent
typhoid
vaccine,
unspecified
formulation
|
71
92
|
http://hl7.org/fhir/sid/cvx
|
respiratory
syncytial
virus
immune
globulin,
intravenous
VEE,
unspecified
formulation
|
RSV-IGIV
Venezuelan
equine
encephalitis
vaccine,
unspecified
formulation
|
|
93
|
http://hl7.org/fhir/sid/cvx
|
RSV-MAb
|
respiratory
syncytial
virus
monoclonal
antibody
(palivizumab),
intramuscular
|
RSV-MAb
06
94
|
http://hl7.org/fhir/sid/cvx
|
rubella
virus
vaccine
MMRV
|
rubella
measles,
mumps,
rubella,
and
varicella
virus
vaccine
|
38
95
|
http://hl7.org/fhir/sid/cvx
|
rubella
and
mumps
virus
vaccine
TST-OT
tine
test
|
rubella/mumps
tuberculin
skin
test;
old
tuberculin,
multipuncture
device
|
76
96
|
http://hl7.org/fhir/sid/cvx
|
Staphylococcus
bacteriophage
lysate
TST-PPD
intradermal
|
Staphylococcus
bacterio
lysate
tuberculin
skin
test;
purified
protein
derivative
solution,
intradermal
|
113
97
|
http://hl7.org/fhir/sid/cvx
|
tetanus
and
diphtheria
toxoids,
adsorbed,
preservative
free,
for
adult
use
(5
Lf
of
tetanus
toxoid
and
2
Lf
of
diphtheria
toxoid)
TST-PPD
tine
test
|
Td
(adult),
5
Lf
tetanus
toxoid,
preservative
free,
adsorbed
tuberculin
skin
test;
purified
protein
derivative,
multipuncture
device
|
09
98
|
http://hl7.org/fhir/sid/cvx
|
tetanus
and
diphtheria
toxoids,
adsorbed,
preservative
free,
for
adult
use
(2
Lf
of
tetanus
toxoid
and
2
Lf
of
diphtheria
toxoid)
TST,
unspecified
formulation
|
Td
(adult),
2
Lf
tetanus
toxoid,
preservative
free,
adsorbed
tuberculin
skin
test;
unspecified
formulation
|
115
99
|
http://hl7.org/fhir/sid/cvx
|
tetanus
toxoid,
reduced
diphtheria
toxoid,
and
acellular
pertussis
vaccine,
adsorbed
RESERVED
-
do
not
use
|
Tdap
RESERVED
-
do
not
use
|
35
100
|
http://hl7.org/fhir/sid/cvx
|
tetanus
toxoid,
adsorbed
pneumococcal
conjugate
PCV
7
|
pneumococcal
conjugate
vaccine,
7
valent
|
112
101
|
http://hl7.org/fhir/sid/cvx
|
tetanus
toxoid,
unspecified
formulation
typhoid,
ViCPs
|
typhoid
Vi
capsular
polysaccharide
vaccine
|
77
102
|
http://hl7.org/fhir/sid/cvx
|
tick-borne
encephalitis
vaccine
DTP-Hib-Hep
B
|
tick-borne
encephalitis
DTP-
Haemophilus
influenzae
type
b
conjugate
and
hepatitis
b
vaccine
|
13
103
|
http://hl7.org/fhir/sid/cvx
|
tetanus
immune
globulin
meningococcal
C
conjugate
|
TIG
meningococcal
C
conjugate
vaccine
|
95
104
|
http://hl7.org/fhir/sid/cvx
|
tuberculin
skin
test;
old
tuberculin,
multipuncture
device
Hep
A-Hep
B
|
TST-OT
tine
test
hepatitis
A
and
hepatitis
B
vaccine
|
96
105
|
http://hl7.org/fhir/sid/cvx
|
tuberculin
skin
test;
purified
protein
derivative
solution,
intradermal
vaccinia
(smallpox)
diluted
|
TST-PPD
intradermal
vaccinia
(smallpox)
vaccine,
diluted
|
97
106
|
http://hl7.org/fhir/sid/cvx
|
tuberculin
skin
test;
purified
protein
derivative,
multipuncture
device
DTaP,
5
pertussis
antigens
|
TST-PPD
tine
test
diphtheria,
tetanus
toxoids
and
acellular
pertussis
vaccine,
5
pertussis
antigens
|
98
107
|
http://hl7.org/fhir/sid/cvx
|
tuberculin
skin
test;
DTaP,
unspecified
formulation
|
TST,
diphtheria,
tetanus
toxoids
and
acellular
pertussis
vaccine,
unspecified
formulation
|
78
108
|
http://hl7.org/fhir/sid/cvx
|
tularemia
vaccine
meningococcal
ACWY,
unspecified
formulation
|
meningococcal
ACWY
vaccine,
unspecified
formulation
|
91
109
|
http://hl7.org/fhir/sid/cvx
|
typhoid
vaccine,
pneumococcal,
unspecified
formulation
|
typhoid,
pneumococcal
vaccine,
unspecified
formulation
|
25
110
|
http://hl7.org/fhir/sid/cvx
|
typhoid
vaccine,
live,
oral
DTaP-Hep
B-IPV
|
typhoid,
oral
DTaP-hepatitis
B
and
poliovirus
vaccine
|
41
111
|
http://hl7.org/fhir/sid/cvx
|
typhoid
vaccine,
parenteral,
other
than
acetone-killed,
dried
influenza,
live,
intranasal
|
typhoid,
parenteral
influenza
virus
vaccine,
live,
attenuated,
for
intranasal
use
|
53
112
|
http://hl7.org/fhir/sid/cvx
|
typhoid
vaccine,
parenteral,
acetone-killed,
dried
(U.S.
military)
tetanus
toxoid,
unspecified
formulation
|
typhoid,
parenteral,
AKD
(U.S.
military)
tetanus
toxoid,
unspecified
formulation
|
101
113
|
http://hl7.org/fhir/sid/cvx
|
typhoid
Vi
capsular
polysaccharide
vaccine
Td
(adult),
5
Lf
tetanus
toxoid,
preservative
free,
adsorbed
|
typhoid,
ViCPs
tetanus
and
diphtheria
toxoids,
adsorbed,
preservative
free,
for
adult
use
(5
Lf
of
tetanus
toxoid
and
2
Lf
of
diphtheria
toxoid)
|
75
114
|
http://hl7.org/fhir/sid/cvx
|
vaccinia
(smallpox)
vaccine
meningococcal
MCV4P
|
vaccinia
(smallpox)
meningococcal
polysaccharide
(groups
A,
C,
Y
and
W-135)
diphtheria
toxoid
conjugate
vaccine
(MCV4P)
|
105
115
|
http://hl7.org/fhir/sid/cvx
|
vaccinia
(smallpox)
vaccine,
diluted
Tdap
|
vaccinia
(smallpox)
diluted
tetanus
toxoid,
reduced
diphtheria
toxoid,
and
acellular
pertussis
vaccine,
adsorbed
|
79
116
|
http://hl7.org/fhir/sid/cvx
|
vaccinia
immune
globulin
rotavirus,
pentavalent
|
rotavirus,
live,
pentavalent
vaccine
|
21
117
|
http://hl7.org/fhir/sid/cvx
|
varicella
virus
vaccine
VZIG
(IND)
|
varicella
zoster
immune
globulin
(Investigational
New
Drug)
|
81
118
|
http://hl7.org/fhir/sid/cvx
|
Venezuelan
equine
encephalitis,
inactivated
HPV,
bivalent
|
VEE,
inactivated
human
papilloma
virus
vaccine,
bivalent
|
80
119
|
http://hl7.org/fhir/sid/cvx
|
Venezuelan
equine
encephalitis,
live,
attenuated
rotavirus,
monovalent
|
VEE,
live
rotavirus,
live,
monovalent
vaccine
|
92
120
|
http://hl7.org/fhir/sid/cvx
|
Venezuelan
equine
encephalitis
vaccine,
unspecified
formulation
DTaP-Hib-IPV
|
VEE,
unspecified
formulation
diphtheria,
tetanus
toxoids
and
acellular
pertussis
vaccine,
Haemophilus
influenzae
type
b
conjugate,
and
poliovirus
vaccine,
inactivated
(DTaP-Hib-IPV)
|
36
121
|
http://hl7.org/fhir/sid/cvx
|
varicella
zoster
immune
globulin
VZIG
117
http://hl7.org/fhir/sid/cvx
live
|
varicella
zoster
immune
globulin
(Investigational
New
Drug)
VZIG
(IND)
vaccine,
live
|
37
122
|
http://hl7.org/fhir/sid/cvx
|
yellow
fever
vaccine
rotavirus,
unspecified
formulation
|
yellow
fever
rotavirus
vaccine,
unspecified
formulation
|
121
123
|
http://hl7.org/fhir/sid/cvx
|
zoster
vaccine,
live
influenza,
H5N1-1203
|
zoster
live
influenza
virus
vaccine,
H5N1,
A/Vietnam/1203/2004
(national
stockpile)
|
998
125
|
http://hl7.org/fhir/sid/cvx
|
no
vaccine
administered
Novel
Influenza-H1N1-09,
nasal
|
Novel
Influenza-H1N1-09,
live
virus
for
nasal
administration
|
999
126
|
http://hl7.org/fhir/sid/cvx
|
unknown
vaccine
or
immune
globulin
Novel
influenza-H1N1-09,
preservative-free
|
unknown
Novel
influenza-H1N1-09,
preservative-free,
injectable
|
99
127
|
http://hl7.org/fhir/sid/cvx
|
RESERVED
-
do
not
use
Novel
influenza-H1N1-09
|
Novel
influenza-H1N1-09,
injectable
|
133
128
|
http://hl7.org/fhir/sid/cvx
|
pneumococcal
conjugate
vaccine,
13
valent
Novel
Influenza-H1N1-09,
all
formulations
|
Pneumococcal
conjugate
PCV
13
Novel
influenza-H1N1-09,
all
formulations
|
134
129
|
http://hl7.org/fhir/sid/cvx
|
Japanese
Encephalitis
vaccine
for
intramuscular
administration
Encephalitis,
unspecified
formulation
|
Japanese
Encephalitis
IM
137
http://hl7.org/fhir/sid/cvx
HPV,
vaccine,
unspecified
formulation
|
136
130
|
http://hl7.org/fhir/sid/cvx
|
meningococcal
oligosaccharide
(groups
A,
C,
Y
and
W-135)
diphtheria
toxoid
conjugate
vaccine
(MCV4O)
DTaP-IPV
|
Meningococcal
MCV4O
Diphtheria,
tetanus
toxoids
and
acellular
pertussis
vaccine,
and
poliovirus
vaccine,
inactivated
|
135
131
|
http://hl7.org/fhir/sid/cvx
|
influenza,
high
dose
seasonal,
preservative-free
Influenza,
high
dose
seasonal
131
http://hl7.org/fhir/sid/cvx
typhus,
historical
|
Historical
record
of
a
typhus
vaccination
|
typhus,
historical
|
132
|
http://hl7.org/fhir/sid/cvx
|
DTaP-IPV-HIB-HEP
B,
historical
|
Historical
diphtheria
and
tetanus
toxoids
and
acellular
pertussis,
poliovirus,
Haemophilus
b
conjugate
and
hepatitis
B
(recombinant)
vaccine.
|
DTaP-IPV-HIB-HEP
B,
historical
128
133
|
http://hl7.org/fhir/sid/cvx
|
Novel
influenza-H1N1-09,
all
formulations
Pneumococcal
conjugate
PCV
13
|
Novel
Influenza-H1N1-09,
all
formulations
pneumococcal
conjugate
vaccine,
13
valent
|
125
134
|
http://hl7.org/fhir/sid/cvx
|
Novel
Influenza-H1N1-09,
live
virus
Japanese
Encephalitis
IM
|
Japanese
Encephalitis
vaccine
for
nasal
intramuscular
administration
|
|
135
|
Novel
Influenza-H1N1-09,
nasal
http://hl7.org/fhir/sid/cvx
|
Influenza,
high
dose
seasonal
|
influenza,
high
dose
seasonal,
preservative-free
|
126
136
|
http://hl7.org/fhir/sid/cvx
|
Novel
influenza-H1N1-09,
preservative-free,
injectable
Meningococcal
MCV4O
|
Novel
influenza-H1N1-09,
preservative-free
meningococcal
oligosaccharide
(groups
A,
C,
Y
and
W-135)
diphtheria
toxoid
conjugate
vaccine
(MCV4O)
|
127
137
|
http://hl7.org/fhir/sid/cvx
|
Novel
influenza-H1N1-09,
injectable
HPV,
unspecified
formulation
|
Novel
influenza-H1N1-09
HPV,
unspecified
formulation
|
|
138
|
http://hl7.org/fhir/sid/cvx
|
Td
(adult)
|
tetanus
and
diphtheria
toxoids,
not
adsorbed,
for
adult
use
|
Td
(adult)
|
139
|
http://hl7.org/fhir/sid/cvx
|
Td(adult)
unspecified
formulation
|
Td(adult)
unspecified
formulation
|
|
140
|
http://hl7.org/fhir/sid/cvx
|
Influenza,
seasonal,
injectable,
preservative
free
|
129
http://hl7.org/fhir/sid/cvx
Japanese
Encephalitis
vaccine,
unspecified
formulation
Japanese
Encephalitis,
unspecified
formulation
Influenza,
seasonal,
injectable,
preservative
free
|
|
141
|
http://hl7.org/fhir/sid/cvx
|
Influenza,
seasonal,
injectable
|
Influenza,
seasonal,
injectable
|
|
142
|
http://hl7.org/fhir/sid/cvx
|
tetanus
toxoid,
not
adsorbed
|
tetanus
toxoid,
not
adsorbed
|
|
143
|
http://hl7.org/fhir/sid/cvx
|
Adenovirus
types
4
and
7
|
Adenovirus,
type
4
and
type
7,
live,
oral
|
Adenovirus
types
4
and
7
|
144
|
http://hl7.org/fhir/sid/cvx
|
seasonal
influenza,
seasonal,
intradermal,
preservative
free
|
seasonal
influenza,
seasonal,
intradermal,
preservative
free
|
|
145
|
http://hl7.org/fhir/sid/cvx
|
RSV-MAb
(new)
|
respiratory
syncytial
virus
monoclonal
antibody
(motavizumab),
intramuscular
|
RSV-MAb
(new)
|
146
|
http://hl7.org/fhir/sid/cvx
|
DTaP,IPV,Hib,HepB
|
Diphtheria
and
Tetanus
Toxoids
and
Acellular
Pertussis
Adsorbed,
Inactivated
Poliovirus,
Haemophilus
b
Conjugate
(Meningococcal
Protein
Conjugate),
and
Hepatitis
B
(Recombinant)
Vaccine.
|
DTaP,IPV,Hib,HepB
|
147
|
http://hl7.org/fhir/sid/cvx
|
meningococcal
MCV4,
unspecified
formulation
|
Meningococcal,
MCV4,
unspecified
conjugate
formulation(groups
A,
C,
Y
and
W-135)
|
meningococcal
MCV4,
unspecified
formulation
|
148
|
http://hl7.org/fhir/sid/cvx
|
Meningococcal
C/Y-HIB
PRP
|
Meningococcal
Groups
C
and
Y
and
Haemophilus
b
Tetanus
Toxoid
Conjugate
Vaccine
|
Meningococcal
C/Y-HIB
PRP
|
149
|
http://hl7.org/fhir/sid/cvx
|
influenza,
live,
intranasal,
quadrivalent
|
influenza,
live,
intranasal,
quadrivalent
|
|
150
|
http://hl7.org/fhir/sid/cvx
|
Influenza,
influenza,
injectable,
quadrivalent,
preservative
free
|
influenza,
Influenza,
injectable,
quadrivalent,
preservative
free
|
|
151
|
http://hl7.org/fhir/sid/cvx
|
influenza
nasal,
unspecified
formulation
|
influenza
nasal,
unspecified
formulation
|
|
152
|
http://hl7.org/fhir/sid/cvx
|
Pneumococcal
Conjugate,
unspecified
formulation
|
Pneumococcal
Conjugate,
unspecified
formulation
|
|
153
|
http://hl7.org/fhir/sid/cvx
|
Influenza,
injectable,
Madin
Darby
Canine
Kidney,
MDCK,
preservative
free
|
Influenza,
injectable,
MDCK,
Madin
Darby
Canine
Kidney,
preservative
free
|
|
154
|
http://hl7.org/fhir/sid/cvx
|
Hep
A,
IG
|
Hepatitis
A
immune
globulin
|
Hep
A,
IG
|
155
|
http://hl7.org/fhir/sid/cvx
|
Seasonal,
trivalent,
influenza,
recombinant,
injectable
influenza
vaccine,
injectable,
preservative
free
|
influenza,
Seasonal,
trivalent,
recombinant,
injectable,
injectable
influenza
vaccine,
preservative
free
|
|
156
|
http://hl7.org/fhir/sid/cvx
|
Rho(D)-IG
|
Rho(D)
Immune
globulin-
IV
or
IM
|
Rho(D)-IG
|
157
|
http://hl7.org/fhir/sid/cvx
|
Rho(D)
Immune
globulin
-
-IG
IM
|
Rho(D)
-IG
Immune
globulin
-
IM
|
|
158
|
http://hl7.org/fhir/sid/cvx
|
influenza,
injectable,
quadrivalent,
contains
preservative
quadrivalent
|
influenza,
injectable,
quadrivalent
quadrivalent,
contains
preservative
|
|
159
|
http://hl7.org/fhir/sid/cvx
|
Rho(D)
-
Unspecified
formulation
|
Rho(D)
-
Unspecified
formulation
|
|
160
|
http://hl7.org/fhir/sid/cvx
|
Influenza
A
monovalent
(H5N1),
adjuvanted,
National
stockpile
2013
ADJUVANTED-2013
|
Influenza
A
monovalent
(H5N1),
ADJUVANTED-2013
801
http://hl7.org/fhir/sid/cvx
AS03
Adjuvant
adjuvanted,
National
stockpile
2013
|
|
161
|
http://hl7.org/fhir/sid/cvx
|
Influenza,
injectable,quadrivalent,
preservative
free,
pediatric
|
Influenza,
injectable,quadrivalent,
preservative
free,
pediatric
|
|
162
|
http://hl7.org/fhir/sid/cvx
|
meningococcal
B
vaccine,
fully
B,
recombinant
|
meningococcal
B,
B
vaccine,
fully
recombinant
|
|
163
|
http://hl7.org/fhir/sid/cvx
|
meningococcal
B,
OMV
|
meningococcal
B
vaccine,
recombinant,
OMV,
adjuvanted
|
meningococcal
B,
OMV
|
164
|
http://hl7.org/fhir/sid/cvx
|
meningococcal
B,
unspecified
formulation
|
meningococcal
B,
unspecified
formulation
|
|
165
|
http://hl7.org/fhir/sid/cvx
|
HPV9
|
Human
Papillomavirus
9-valent
vaccine
|
HPV9
|
166
|
http://hl7.org/fhir/sid/cvx
|
influenza,
intradermal,
quadrivalent,
preservative
free,
injectable
free
|
influenza,
intradermal,
quadrivalent,
preservative
free
free,
injectable
|
|
167
|
http://hl7.org/fhir/sid/cvx
|
meningococcal,
unknown
serogroups
|
meningococcal
vaccine
of
unknown
formulation
and
unknown
serogroups
|
meningococcal,
unknown
serogroups
|
168
|
http://hl7.org/fhir/sid/cvx
|
influenza,
trivalent,
adjuvanted
|
Seasonal
trivalent
influenza
vaccine,
adjuvanted,
preservative
free
|
influenza,
trivalent,
adjuvanted
|
169
|
http://hl7.org/fhir/sid/cvx
|
Hep
A,
live
attenuated-IM
attenuated
|
Hep
A,
live
attenuated
attenuated-IM
|
|
170
|
http://hl7.org/fhir/sid/cvx
|
DTAP/IPV/HIB
-
non-US
|
non-US
diphtheria,
tetanus
toxoids
and
acellular
pertussis
vaccine,
Haemophilus
influenzae
type
b
conjugate,
and
poliovirus
vaccine,
inactivated
(DTaP-Hib-IPV)
|
DTAP/IPV/HIB
-
non-US
|
171
|
http://hl7.org/fhir/sid/cvx
|
Influenza,
injectable,
Madin
Darby
Canine
Kidney,
MDCK,
preservative
free,
quadrivalent
|
Influenza,
injectable,
MDCK,
Madin
Darby
Canine
Kidney,
preservative
free,
quadrivalent
|
|
172
|
http://hl7.org/fhir/sid/cvx
|
cholera,
WC-rBS
|
cholera,
WC-rBS
|
|
173
|
http://hl7.org/fhir/sid/cvx
|
cholera,
BivWC
|
cholera,
BivWC
|
|
174
|
http://hl7.org/fhir/sid/cvx
|
cholera,
live
attenuated
|
cholera,
live
attenuated
|
|
175
|
http://hl7.org/fhir/sid/cvx
|
Human
Rabies
vaccine
from
human
diploid
-
IM
Diploid
cell
culture
|
Human
Rabies
-
IM
Diploid
vaccine
from
human
diploid
cell
culture
|
|
176
|
http://hl7.org/fhir/sid/cvx
|
Rabies
-
IM
fibroblast
culture
|
Human
rabies
vaccine
from
Chicken
fibroblast
culture
|
Rabies
-
IM
fibroblast
culture
|
177
|
http://hl7.org/fhir/sid/cvx
|
PCV10
|
pneumococcal
conjugate
vaccine,
10
valent
|
PCV10
|
178
|
http://hl7.org/fhir/sid/cvx
|
OPV
bivalent
|
Non-US
bivalent
oral
polio
vaccine
(types
1
and
3)
|
OPV
bivalent
|
179
|
http://hl7.org/fhir/sid/cvx
|
OPV
,monovalent,
unspecified
|
Non-US
monovalent
oral
polio
vaccine,
unspecified
formulation
|
OPV
,monovalent,
unspecified
|
180
|
http://hl7.org/fhir/sid/cvx
|
tetanus
immune
globulin
|
tetanus
immune
globulin
|
|
181
|
http://hl7.org/fhir/sid/cvx
|
anthrax
immune
globulin
|
anthrax
immune
globulin
|
|
182
|
http://hl7.org/fhir/sid/cvx
|
OPV,
Unspecified
|
Oral
Polio
Vaccine,
Unspecified
formulation
|
OPV,
Unspecified
|
183
|
http://hl7.org/fhir/sid/cvx
|
Yellow
fever
vaccine
alternative
formulation
-
alt
|
Yellow
fever
vaccine
-
alt
alternative
formulation
|
|
184
|
http://hl7.org/fhir/sid/cvx
|
Yellow
fever
vaccine,
fever,
unspecified
formulation
|
Yellow
fever,
fever
vaccine,
unspecified
formulation
|
|
185
|
http://hl7.org/fhir/sid/cvx
|
Seasonal,
quadrivalent,
influenza,
recombinant,
injectable
influenza
vaccine,
quadrivalent,injectable,
preservative
free
|
influenza,
Seasonal,
quadrivalent,
recombinant,
quadrivalent,injectable,
injectable
influenza
vaccine,
preservative
free
|
|
186
|
http://hl7.org/fhir/sid/cvx
|
Influenza,
injectable,
MDCK,
quadrivalent,
preservative
|
Influenza,
injectable,
Madin
Darby
Canine
Kidney,
quadrivalent
with
preservative
|
Influenza,
injectable,
MDCK,
quadrivalent,
preservative
|
187
|
http://hl7.org/fhir/sid/cvx
|
zoster
vaccine
recombinant
|
zoster
vaccine
recombinant
|
|
188
|
http://hl7.org/fhir/sid/cvx
|
zoster
vaccine,
zoster,
unspecified
formulation
|
zoster,
zoster
vaccine,
unspecified
formulation
|
|
189
|
http://hl7.org/fhir/sid/cvx
|
HepB-CpG
|
Hepatitis
B
vaccine
(recombinant),
CpG
adjuvanted
|
HepB-CpG
|
190
|
http://hl7.org/fhir/sid/cvx
|
Typhoid
conjugate
vaccine
(non-US)
(TCV)
|
Typhoid
conjugate
vaccine
(TCV)
(non-US)
|
|
191
|
http://hl7.org/fhir/sid/cvx
|
meningococcal
A
polysaccharide
vaccine
(non-US)
|
meningococcal
A
polysaccharide
vaccine
(non-US)
|
|
192
|
http://hl7.org/fhir/sid/cvx
|
meningococcal
AC
polysaccharide
vaccine
(non-US)
|
meningococcal
AC
polysaccharide
vaccine
(non-US)
|
|
193
|
http://hl7.org/fhir/sid/cvx
|
Hep
A-Hep
B,
pediatric/adolescent
|
hepatitis
A
and
hepatitis
B
vaccine,
pediatric/adolescent
(non-US)
|
Hep
A-Hep
B,
pediatric/adolescent
|
194
|
http://hl7.org/fhir/sid/cvx
|
Influenza,
Southern
Hemisphere
|
influenza,
Southern
Hemisphere,
unspecified
formulation
|
Influenza,
Southern
Hemisphere
|
195
|
http://hl7.org/fhir/sid/cvx
|
Diphtheria,
Tetanus,
Poliomyelitis
DT,
IPV
adsorbed
|
DT,
IPV
Diphtheria,
Tetanus,
Poliomyelitis
adsorbed
|
|
196
|
http://hl7.org/fhir/sid/cvx
|
tetanus
and
diphtheria
toxoids,
Td,
adsorbed,
preservative
free,
for
adult
use,
Lf
unspecified
|
Td,
tetanus
and
diphtheria
toxoids,
adsorbed,
preservative
free,
for
adult
use,
Lf
unspecified
|
|
197
|
http://hl7.org/fhir/sid/cvx
|
influenza,
high-dose,
quadrivalent
|
influenza,
high-dose
seasonal,
quadrivalent,
.7mL
0.7mL
dose,
preservative
free
|
|
198
|
influenza,
high-dose,
quadrivalent
http://hl7.org/fhir/sid/cvx
|
DTP-hepB-Hib
Pentavalent
Non-US
|
Diphtheria,
pertussis,
tetanus,
hepatitis
B,
Haemophilus
Influenza
Type
b,
(Pentavalent)
|
|
200
|
http://hl7.org/fhir/sid/cvx
|
influenza,
Southern
Hemisphere,
pediatric,
preservative
free
|
influenza,
seasonal,
Southern
Hemisphere,
quadrivalent,
pediatric
0.25mL
dose,
preservative
free
|
|
201
|
http://hl7.org/fhir/sid/cvx
|
influenza,
Southern
Hemisphere,
pediatric,
preservative
free
|
influenza,
seasonal,
Southern
Hemisphere,
quadrivalent,
0.5mL
dose,
no
preservative
|
201
202
|
http://hl7.org/fhir/sid/cvx
|
influenza,
Southern
Hemisphere,
quadrivalent,
with
preservative
|
influenza,
seasonal,
Southern
Hemisphere,
quadrivalent,
0.5mL
dose,
no
with
preservative
|
|
203
|
influenza,
Southern
Hemisphere,
http://hl7.org/fhir/sid/cvx
|
meningococcal
conjugate
quadrivalent,
MenACWY-TT
(MCV4)
|
meningococcal
polysaccharide
(groups
A,
C,
Y,
W-135)
tetanus
toxoid
conjugate
vaccine
0.5mL
dose,
preservative
free
|
202
204
|
http://hl7.org/fhir/sid/cvx
|
Ebola
Zaire
vaccine,
live,
recombinant,
1mL
dose
|
Ebola
Zaire
vaccine,
live,
recombinant,
1mL
dose
|
|
205
|
http://hl7.org/fhir/sid/cvx
|
Influenza
vaccine,
quadrivalent,
adjuvanted
|
influenza,
seasonal,
Southern
Hemisphere,
seasonal
vaccine,
quadrivalent,
adjuvanted,
0.5mL
dose,
with
preservative
free
|
|
206
|
influenza,
Southern
Hemisphere,
quadrivalent,
with
http://hl7.org/fhir/sid/cvx
|
Vaccinia,
smallpox
Mpox
vaccine
live,
PF,
SQ
or
ID
injection
|
Vaccinia,
smallpox
monkeypox
vaccine,
live
attenuated,
preservative
free,
subcutaneous
or
intradermal
injection
|
198
207
|
http://hl7.org/fhir/sid/cvx
|
COVID-19,
mRNA,
LNP-S,
PF,
100
mcg/0.5mL
dose
or
50
mcg/0.25mL
dose
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
100
mcg/0.5mL
dose
or
50
mcg/0.25mL
dose
|
|
208
|
http://hl7.org/fhir/sid/cvx
|
COVID-19,
mRNA,
LNP-S,
PF,
30
mcg/0.3
mL
dose
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
30
mcg/0.3mL
dose
|
|
210
|
Diphtheria,
pertussis,
tetanus,
hepatitis
B,
Haemophilus
Influenza
Type
b,
(Pentavalent)
http://hl7.org/fhir/sid/cvx
|
COVID-19
vaccine,
vector-nr,
rS-ChAdOx1,
PF,
0.5
mL
|
SARS-COV-2
(COVID-19)
vaccine,
vector
non-replicating,
recombinant
spike
protein-ChAdOx1,
preservative
free,
0.5
mL
|
|
211
|
DTP-hepB-Hib
Pentavalent
Non-US
http://hl7.org/fhir/sid/cvx
|
COVID-19,
subunit,
rS-nanoparticle+Matrix-M1
Adjuvant,
PF,
0.5
mL
|
SARS-COV-2
(COVID-19)
vaccine,
subunit,
recombinant
spike
protein-nanoparticle+Matrix-M1
Adjuvant,
preservative
free,
0.5mL
dose
|
|
212
|
http://hl7.org/fhir/sid/cvx
|
COVID-19
vaccine,
vector-nr,
rS-Ad26,
PF,
0.5
mL
|
SARS-COV-2
(COVID-19)
vaccine,
vector
non-replicating,
recombinant
spike
protein-Ad26,
preservative
free,
0.5
mL
|
203
213
|
http://hl7.org/fhir/sid/cvx
|
SARS-COV-2
(COVID-19)
vaccine,
UNSPECIFIED
|
SARS-COV-2
(COVID-19)
vaccine,
UNSPECIFIED
|
|
214
|
http://hl7.org/fhir/sid/cvx
|
Ebola,
unspecified
|
Ebola,
unspecified
|
|
215
|
meningococcal
http://hl7.org/fhir/sid/cvx
|
Pneumococcal
conjugate
PCV15,
polysaccharide
(groups
A,
C,
Y,
W-135)
tetanus
toxoid
CRM197
conjugate,
adjuvant,
PF
|
Pneumococcal
conjugate
vaccine
.5mL
dose,
15-valent
(PCV15),
polysaccharide
CRM197
conjugate,
adjuvant,
preservative
free
|
|
216
|
meningococcal
http://hl7.org/fhir/sid/cvx
|
Pneumococcal
conjugate
PCV20,
polysaccharide
(groups
A,
C,
Y,
W-135)
TT
CRM197
conjugate,
adjuvant,
PF
|
Pneumococcal
conjugate
vaccine
20-valent
(PCV20),
polysaccharide
CRM197
conjugate,
adjuvant,
preservative
free
|
205
217
|
http://hl7.org/fhir/sid/cvx
|
influenza,
seasonal
COVID-19,
mRNA,
LNP-S,
PF,
30
mcg/0.3
mL
dose,
tris-sucrose
|
SARS-COV-2
(COVID-19)
vaccine,
quadrivalent,
adjuvanted,
.5mL
mRNA,
spike
protein,
LNP,
preservative
free,
30
mcg/0.3mL
dose,
tris-sucrose
formulation
|
|
218
|
http://hl7.org/fhir/sid/cvx
|
COVID-19,
mRNA,
LNP-S,
PF,
10
mcg/0.2
mL
dose,
tris-sucrose
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free
free,
10
mcg/0.2mL
dose,
tris-sucrose
formulation
|
|
219
|
Influenza
http://hl7.org/fhir/sid/cvx
|
COVID-19,
mRNA,
LNP-S,
PF,
3
mcg/0.2
mL
dose,
tris-sucrose
|
SARS-COV-2
(COVID-19)
vaccine,
quadrivalent,
adjuvanted
mRNA,
spike
protein,
LNP,
preservative
free,
3
mcg/0.2mL
dose,
tris-sucrose
formulation
|
|
220
|
http://hl7.org/fhir/sid/cvx
|
HepB
recombinant,
3-antigen,
Al(OH)3
|
Hepatitis
B
vaccine
(recombinant),
3-antigen,
Al(OH)3
adjuvanted
|
206
221
|
http://hl7.org/fhir/sid/cvx
|
COVID-19,
mRNA,
LNP-S,
PF,
50
mcg/0.5
mL
dose
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
50
mcg/0.5
mL
dose
|
|
222
|
http://hl7.org/fhir/sid/cvx
|
Tick-borne
encephalitis,
unspecified
|
Tick-borne
encephalitis
vaccine,
unspecified
|
|
223
|
smallpox
monkeypox
http://hl7.org/fhir/sid/cvx
|
Tick-borne
encephalitis,
inactivated,
PF,
0.25mL
|
Tick-borne
encephalitis
vaccine,
live
attenuated,
inactivated,
preservative
free
(National
Stockpile)
free,
0.25mL
dose
|
|
224
|
Smallpox
monkeypox
vaccine
(National
Stockpile)
http://hl7.org/fhir/sid/cvx
|
Tick-borne
encephalitis,
inactivated,
PF,
0.5mL
|
Tick-borne
encephalitis
vaccine,
inactivated,
preservative
free,
0.5mL
dose
|
|
225
|
http://hl7.org/fhir/sid/cvx
|
COVID-19,
D614,
recomb,
preS
dTM,
AS03
adjuvant
add,
PF,
5mcg/0.5mL
|
SARS-COV-2
(COVID-19)
vaccine,
D614,
prefusion
spike
recombinant
protein
subunit
(CoV2
preS
dTM),
AS03
adjuvant
added,
preservative
free,
5mcg/0.5mL
dose
|
207
226
|
http://hl7.org/fhir/sid/cvx
|
COVID-19,
D614,
recomb,
preS
dTM,
AS03
adjuvant
add,
PF,
10mcg/0.5mL
|
SARS-COV-2
(COVID-19)
vaccine,
D614,
prefusion
spike
recombinant
protein
subunit
(CoV2
preS
dTM),
AS03
adjuvant
added,
preservative
free,
10mcg/0.5mL
dose
|
|
227
|
http://hl7.org/fhir/sid/cvx
|
COVID-19,
mRNA,
LNP-S,
PF,
pediatric
50
mcg/0.5
mL
dose
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
pediatric
50
mcg/0.5
mL
dose
|
|
228
|
http://hl7.org/fhir/sid/cvx
|
COVID-19,
mRNA,
LNP-S,
PF,
pediatric
25
mcg/0.25
mL
dose
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
100
mcg/0.5mL
pediatric
25
mcg/0.25
mL
dose
|
|
229
|
http://hl7.org/fhir/sid/cvx
|
COVID-19,
mRNA,
LNP-S,
bivalent,
PF,
100
50
mcg/0.5
mL
or
25mcg/0.25
mL
dose
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
bivalent,
preservative
free,
50
mcg/0.5
mL
or
25
mcg/0.25
mL
dose
|
208
230
|
http://hl7.org/fhir/sid/cvx
|
COVID-19,
mRNA,
LNP-S,
bivalent,
PF,
10
mcg/0.2
mL
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
bivalent,
preservative
free,
30
mcg/0.3mL
10
mcg/0.2
mL
dose
|
|
231
|
http://hl7.org/fhir/sid/cvx
|
influenza,
Southern
Hemisphere,
high-dose,
quadrivalent
|
influenza,
seasonal,
Southern
Hemisphere,
high-dose,
quadrivalent,
0.7mL
dose,
preservative
free
|
|
300
|
http://hl7.org/fhir/sid/cvx
|
COVID-19,
mRNA,
LNP-S,
bivalent,
PF,
30
mcg/0.3
mL
dose
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
bivalent,
preservative
free,
30
mcg/0.3
mL
dose,
tris-sucrose
formulation
|
213
301
|
http://hl7.org/fhir/sid/cvx
|
COVID-19,
mRNA,
LNP-S,
bivalent,
PF,
10
mcg/0.2
mL
dose
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
bivalent,
preservative
free,
10
mcg/0.2
mL
dose,
tris-sucrose
formulation
|
|
302
|
http://hl7.org/fhir/sid/cvx
|
COVID-19,
mRNA,
LNP-S,
bivalent,
PF,
3
mcg/0.2
mL
dose
|
SARS-COV-2
(COVID-19)
vaccine,
UNSPECIFIED
mRNA,
spike
protein,
LNP,
bivalent,
preservative
free,
3
mcg/0.2
mL
dose,
tris-sucrose
formulation
|
|
303
|
http://hl7.org/fhir/sid/cvx
|
RSV,
recombinant,
protein
subunit
RSVpreF,
adjuvant
reconstituted,
0.5
mL,
PF
|
Respiratory
syncytial
virus
(RSV),
vaccine,
recombinant,
protein
subunit
RSV
prefusion
F,
adjuvant
reconstituted,
0.5
mL,
preservative
free
|
|
304
|
http://hl7.org/fhir/sid/cvx
|
Respiratory
syncytial
virus
(RSV),
unspecified
|
Respiratory
syncytial
virus
(RSV),
unspecified
|
|
305
|
http://hl7.org/fhir/sid/cvx
|
RSV,
bivalent,
protein
subunit
RSVpreF,
diluent
reconstituted,
0.5
mL,
PF
|
Respiratory
syncytial
virus
(RSV),
vaccine,
bivalent,
protein
subunit
RSV
prefusion
F,
diluent
reconstituted,
0.5
mL,
preservative
free
|
210
306
|
http://hl7.org/fhir/sid/cvx
|
RSV,
mAb,
nirsevimab-alip,
0.5
mL,
neonate
to
24
months
|
Respiratory
syncytial
virus
(RSV)
monoclonal
antibody,
IgG1κ
,
(nirsevimab-alip),
0.5
mL,
neonates
and
children
to
24
months
|
|
307
|
http://hl7.org/fhir/sid/cvx
|
RSV,
mAb,
nirsevimab-alip,
1
mL,
neonate
to
24
months
|
Respiratory
syncytial
virus
(RSV)
monoclonal
antibody,
IgG1κ
,
(nirsevimab-alip),
1
mL,
neonates
and
children
to
24
months
|
|
308
|
http://hl7.org/fhir/sid/cvx
|
COVID-19,
mRNA,
LNP-S,
PF,
tris-sucrose,
3
mcg/0.3
mL
|
SARS-COV-2
(COVID-19)
vaccine,
vector
non-replicating,
recombinant
mRNA,
spike
protein-ChAdOx1,
protein,
LNP,
preservative
free,
0.5
tris-sucrose,
3
mcg/0.3
mL
dose
|
|
309
|
COVID-19
vaccine,
vector-nr,
rS-ChAdOx1,
http://hl7.org/fhir/sid/cvx
|
COVID-19,
mRNA,
LNP-S,
PF,
0.5
tris-sucrose,
30
mcg/0.3
mL
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
tris-sucrose,
30
mcg/0.3
mL
dose
|
|
310
|
http://hl7.org/fhir/sid/cvx
|
COVID-19,
mRNA,
LNP-S,
PF,
tris-sucrose,
10
mcg/0.3
mL
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
tris-sucrose,
10
mcg/0.3
mL
dose
|
212
311
|
http://hl7.org/fhir/sid/cvx
|
COVID-19,
mRNA,
LNP-S,
PF,
25
mcg/0.25
mL
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
25
mcg/0.25
mL
dose
|
|
312
|
http://hl7.org/fhir/sid/cvx
|
COVID-19,
mRNA,
LNP-S,
PF,
50
mcg/0.5
mL
|
SARS-COV-2
(COVID-19)
vaccine,
mRNA,
spike
protein,
LNP,
preservative
free,
50
mcg/0.5
mL
dose
|
|
313
|
http://hl7.org/fhir/sid/cvx
|
COVID-19,
subunit,
rS-nanoparticle,
adjuvanted,
PF,
5
mcg/0.5
mL
|
SARS-COV-2
(COVID-19)
vaccine,
vector
non-replicating,
subunit,
recombinant
spike
protein-Ad26,
protein-nanoparticle+Matrix-M1
Adjuvant,
preservative
free,
0.5
ml
5
mcg/0.5
mL
dose
|
|
314
|
COVID-19
http://hl7.org/fhir/sid/cvx
|
Respiratory
syncytial
virus
(RSV)
vaccine,
unspecified
|
Respiratory
syncytial
virus
(RSV)
vaccine,
unspecified
|
|
315
|
http://hl7.org/fhir/sid/cvx
|
Respiratory
syncytial
virus
(RSV)
MAB,
unspecified
|
Respiratory
syncytial
virus
(RSV)
monoclonal
antibody
(MAB),
unspecified
|
|
316
|
http://hl7.org/fhir/sid/cvx
|
meningococcal
polysaccharide
(MenACWY-TT
conjugate),
(MenB),
PF
|
meningococcal
polysaccharide
(groups
A,
C,
Y,
W)
tetanus
toxoid
conjugate,
meningococcal
B
recombinant
vaccine,
0.5mL,
preservative
free
|
|
317
|
http://hl7.org/fhir/sid/cvx
|
Chikungunya
live
attenuated
vaccine,
vector-nr,
rS-Ad26,
PF,
0.5
mL
mL,
PF
|
Chikungunya,
live
attenuated
vaccine,
0.5
mL,
preservative
free
|
|
500
|
http://hl7.org/fhir/sid/cvx
|
COVID-19
Non-US
Vaccine,
Product
Unknown
|
SARS-COV-2
COVID-19
Non-US
Vaccine,
Specific
Product
Unknown
|
204
501
|
http://hl7.org/fhir/sid/cvx
|
COVID-19
IV
Non-US
Vaccine
(QAZCOVID-IN)
|
SARS-COV-2
COVID-19
Inactivated
Virus
Non-US
Vaccine
Product
(QAZCOVID-IN)
|
|
502
|
http://hl7.org/fhir/sid/cvx
|
COVID-19
IV
Non-US
Vaccine
(COVAXIN)
|
SARS-COV-2
COVID-19
Inactivated
Virus
Non-US
Vaccine
Product
(COVAXIN)
|
|
503
|
Ebola
Zaire
vaccine,
live,
recombinant,
1mL
dose
http://hl7.org/fhir/sid/cvx
|
COVID-19
LAV
Non-US
Vaccine
(COVIVAC)
|
SARS-COV-2
COVID-19
Live
Attenuated
Virus
Non-US
Vaccine
Product
(COVIVAC)
|
|
504
|
http://hl7.org/fhir/sid/cvx
|
COVID-19
VVnr
Non-US
Vaccine
(Sputnik
Light)
|
SARS-COV-2
COVID-19
Viral
Vector
Non-replicating
Non-US
Vaccine
Product
(Sputnik
Light)
|
|
505
|
http://hl7.org/fhir/sid/cvx
|
COVID-19
VVnr
Non-US
Vaccine
(Sputnik
V)
|
SARS-COV-2
COVID-19
Viral
Vector
Non-replicating
Non-US
Vaccine
Product
(Sputnik
V)
|
|
506
|
http://hl7.org/fhir/sid/cvx
|
COVID-19
VVnr
Non-US
Vaccine
(CanSino
Biological
Inc./Beijing
Institute
of
Biotechnology
|
SARS-COV-2
COVID-19
Viral
Vector
Non-replicating
Non-US
Vaccine
Product
(CONVIDECIA),
CanSino
Biological
Inc./Beijing
Institute
of
Biotechnology
|
214
507
|
http://hl7.org/fhir/sid/cvx
|
COVID-19
PS
Non-US
Vaccine
(Anhui
Zhifei
Longcom
Biopharm
+
Inst
of
Micro,
Chinese
Acad
of
Sciences)
|
SARS-COV-2
COVID-19
Protein
Subunit
Non-US
Vaccine
Product
(Anhui
Zhifei
Longcom
Biopharmaceutical
+
Institute
of
Microbiology,
Chinese
Academy
of
Sciences)
|
|
508
|
http://hl7.org/fhir/sid/cvx
|
COVID-19
PS
Non-US
Vaccine
(Jiangsu
Province
Centers
for
Disease
Control
and
Prevention)
|
SARS-COV-2
COVID-19
Protein
Subunit
Non-US
Vaccine
Product
(Jiangsu
Province
Centers
for
Disease
Control
and
Prevention)
|
|
509
|
Ebola,
unspecified
http://hl7.org/fhir/sid/cvx
|
COVID-19
PS
Non-US
Vaccine
(EpiVacCorona)
|
SARS-COV-2
COVID-19
Protein
Subunit
Non-US
Vaccine
Product
(EpiVacCorona)
|
|
510
|
http://hl7.org/fhir/sid/cvx
|
COVID-19
IV
Non-US
Vaccine
(BIBP,
Sinopharm)
|
SARS-COV-2
COVID-19
Inactivated
Virus
Non-US
Vaccine
Product
(BIBP,
Sinopharm)
|
|
511
|
http://hl7.org/fhir/sid/cvx
|
COVID-19
IV
Non-US
Vaccine
(CoronaVac,
Sinovac)
|
SARS-COV-2
COVID-19
Inactivated
Virus
Non-US
Vaccine
Product
(CoronaVac,
Sinovac)
|
|
512
|
http://hl7.org/fhir/sid/cvx
|
SARS-COV-2
COVID-19
VLP
Non-US
Vaccine
(Medicago,
Covifenz)
|
SARS-COV-2
COVID-19
Virus
Like
Particle
(VLP)
Non-US
Vaccine
Product
(Medicago,
Covifenz)
|
211
513
|
http://hl7.org/fhir/sid/cvx
|
SARS-COV-2
COVID-19
PS
Non-US
Vaccine
(Anhui
Zhifei
Longcom,
Zifivax)
|
SARS-COV-2
COVID-19
Protein
Subunit
Non-US
Vaccine
Product
(Anhui
Zhifei
Longcom,
Zifivax)
|
|
514
|
http://hl7.org/fhir/sid/cvx
|
SARS-COV-2
COVID-19
DNA
Non-US
Vaccine
(Zydus
Cadila,
ZyCoV-D)
|
SARS-COV-2
COVID-19
DNA
Non-US
Vaccine
Product
(Zydus
Cadila,
ZyCoV-D)
|
|
515
|
http://hl7.org/fhir/sid/cvx
|
SARS-COV-2
(COVID-19)
vaccine,
Subunit,
recombinant
spike
protein-nanoparticle+Matrix-M1
Adjuvant,
preservative
free,
0.5mL
per
dose
COVID-19
PS
Non-US
Vaccine
(Medigen,
MVC-COV1901)
|
SARS-COV-2
COVID-19
Protein
Subunit
Non-US
Vaccine
Product
(Medigen,
MVC-COV1901)
|
|
516
|
http://hl7.org/fhir/sid/cvx
|
COV-2
COVID-19
vaccine,
Subunit,
rS-nanoparticle+Matrix-M1
Adjuvant,
PF,
0.5
mL
Inactivated
Non-US
Vaccine
Product
(Minhai
Biotechnology
Co,
KCONVAC)
|
SARS-COV-2
COVID-19
Inactivated
Non-US
Vaccine
Product
(Minhai
Biotechnology
Co,
KCONVAC)
|
|
517
|
http://hl7.org/fhir/sid/cvx
|
SARS-COV-2
COVID-19
PS
Non-US
Vaccine
(Biological
E
Limited,
Corbevax)
|
SARS-COV-2
COVID-19
Protein
Subunit
Non-US
Vaccine
Product
(Biological
E
Limited,
Corbevax)
|
AGRPAL
518
|
http://hl7.org/fhir/sid/cvx
|
COVID-19
Inactivated,
Non-US
Vaccine
(VLA2001,
Valneva)
|
SARS-COV-2
COVID-19
Inactivated,
Non-US
Vaccine
(VLA2001,
Valneva)
|
|
519
|
urn:oid:1.2.36.1.2001.1005.17
http://hl7.org/fhir/sid/cvx
|
COVID-19
mRNA,
bivalent,
original/Omicron
BA.1,
Non-US
Vaccine
(Spikevax
Bivalent),
Moderna
|
SARS-COV-2
COVID-19
mRNA,
bivalent,
original/Omicron
BA.1,
Non-US
Vaccine
(Spikevax
Bivalent),
Moderna
|
|
520
|
Agrippal
http://hl7.org/fhir/sid/cvx
|
COVID-19
mRNA,
bivalent,
original/Omicron
BA.1,
Non-US
Vaccine
Product,
Pfizer-BioNTech
|
SARS-COV-2
COVID-19
mRNA,
bivalent,
original/Omicron
BA.1,
Non-US
Vaccine
Product
(Comirnaty
Bivalent),
Pfizer-BioNTech
|
|
521
|
http://hl7.org/fhir/sid/cvx
|
COVID-19
SP,
protein-based,
adjuvanted
(VidPrevtyn
Beta),
Sanofi-GSK
|
SARS-COV-2
(COVID-19)
vaccine
SP,
protein-based,
adjuvanted,
B.1.351
strain
(VidPrevtyn
Beta),
Sanofi-GSK
|
|
801
|
http://hl7.org/fhir/sid/cvx
|
AS03
Adjuvant
|
AS03
Adjuvant
|
|
998
|
http://hl7.org/fhir/sid/cvx
|
no
vaccine
administered
|
no
vaccine
administered
|
AVAXM
999
|
http://hl7.org/fhir/sid/cvx
|
unknown
|
unknown
vaccine
or
immune
globulin
|
|
AGRPAL
|
urn:oid:1.2.36.1.2001.1005.17
|
Agrippal
| |
|
AVAXM
|
urn:oid:1.2.36.1.2001.1005.17
|
Avaxim
|
|
|
BCG
|
urn:oid:1.2.36.1.2001.1005.17
|
BCG
|
|
|
CDT
|
urn:oid:1.2.36.1.2001.1005.17
|
CDT
|
|
|
CMX
|
urn:oid:1.2.36.1.2001.1005.17
|
COMVAX
|
|
|
DTP
|
urn:oid:1.2.36.1.2001.1005.17
|
Triple
Antigen
|
|
|
DTPA
|
urn:oid:1.2.36.1.2001.1005.17
|
DTPa
|
|
|
ENGP
|
urn:oid:1.2.36.1.2001.1005.17
|
Engerix
B
|
|
|
FLRIX
|
urn:oid:1.2.36.1.2001.1005.17
|
Fluarix
|
|
|
FLUVAX
|
urn:oid:1.2.36.1.2001.1005.17
|
Fluvax
|
|
|
FLVRN
|
urn:oid:1.2.36.1.2001.1005.17
|
Fluvirin
|
|
|
FVXJNR
|
urn:oid:1.2.36.1.2001.1005.17
|
Fluvax
Junior
|
|
|
GNDIP
|
urn:oid:1.2.36.1.2001.1005.17
|
Diphtheria
|
|
|
GNFLU
|
urn:oid:1.2.36.1.2001.1005.17
|
Influenza
|
|
|
GNHEP
|
urn:oid:1.2.36.1.2001.1005.17
|
Hepatitis
B
|
|
|
GNHIB
|
urn:oid:1.2.36.1.2001.1005.17
|
HIB
|
|
|
GNHPA
|
urn:oid:1.2.36.1.2001.1005.17
|
Hepatitis
A
|
|
|
GNJEN
|
urn:oid:1.2.36.1.2001.1005.17
|
Japanese
Encephalitis
|
|
|
GNMEA
|
urn:oid:1.2.36.1.2001.1005.17
|
Measles
|
|
|
GNMEN
|
urn:oid:1.2.36.1.2001.1005.17
|
Meningococcal
C
|
|
|
GNMUM
|
urn:oid:1.2.36.1.2001.1005.17
|
Mumps
|
|
|
GNPNE
|
urn:oid:1.2.36.1.2001.1005.17
|
Pneumococcal
|
|
|
GNPOL
|
urn:oid:1.2.36.1.2001.1005.17
|
Polio
|
|
|
GNROX
|
urn:oid:1.2.36.1.2001.1005.17
|
Rotavirus
|
|
|
GNRUB
|
urn:oid:1.2.36.1.2001.1005.17
|
Rubella
|
|
|
GNTET
|
urn:oid:1.2.36.1.2001.1005.17
|
Tetanus
|
|
|
GNVAR
|
urn:oid:1.2.36.1.2001.1005.17
|
Varicella
|
|
|
HATWNJ
|
urn:oid:1.2.36.1.2001.1005.17
|
Twinrix
Junior
|
|
|
HAVAQ
|
urn:oid:1.2.36.1.2001.1005.17
|
Vaqta
Paed/Adol
|
|
|
HAVJ
|
urn:oid:1.2.36.1.2001.1005.17
|
Havrix
Junior
|
|
|
HBOC
|
urn:oid:1.2.36.1.2001.1005.17
|
HibTITER
|
|
|
HBV
|
urn:oid:1.2.36.1.2001.1005.17
|
HBV
|
|
|
HBVP
|
urn:oid:1.2.36.1.2001.1005.17
|
HBVAX
II
|
|
|
HBX
|
urn:oid:1.2.36.1.2001.1005.17
|
Hiberix
|
|
|
IFHX
|
urn:oid:1.2.36.1.2001.1005.17
|
Infanrix
Hexa
|
|
|
IFIP
|
urn:oid:1.2.36.1.2001.1005.17
|
Infanrix-IPV
|
|
|
IFPA
|
urn:oid:1.2.36.1.2001.1005.17
|
Infanrix
Penta
|
|
|
IFX
|
urn:oid:1.2.36.1.2001.1005.17
|
Infanrix
|
|
|
IFXB
|
urn:oid:1.2.36.1.2001.1005.17
|
InfanrixHepB
|
|
|
INFLUV
|
urn:oid:1.2.36.1.2001.1005.17
|
Influvac
|
|
|
IPV
|
urn:oid:1.2.36.1.2001.1005.17
|
IPOL
|
|
|
JEVAX
|
urn:oid:1.2.36.1.2001.1005.17
|
JE-VAX
|
|
|
MENJUG
|
urn:oid:1.2.36.1.2001.1005.17
|
Menjugate
|
|
|
MENTEC
|
urn:oid:1.2.36.1.2001.1005.17
|
Meningitec
|
|
|
MENUME
|
urn:oid:1.2.36.1.2001.1005.17
|
Menomune
|
|
|
MENVAX
|
urn:oid:1.2.36.1.2001.1005.17
|
Mencevax
ACWY
|
|
|
MMR
|
urn:oid:1.2.36.1.2001.1005.17
|
MMR
|
|
|
MMRCSL
|
urn:oid:1.2.36.1.2001.1005.17
|
MMR
II
|
|
|
MMRSKB
|
urn:oid:1.2.36.1.2001.1005.17
|
Priorix
|
|
|
MNTRX
|
urn:oid:1.2.36.1.2001.1005.17
|
Menitorix
|
|
|
NEISVC
|
urn:oid:1.2.36.1.2001.1005.17
|
NeisVac-C
|
|
|
OPV
|
urn:oid:1.2.36.1.2001.1005.17
|
Polio
|
|
|
P
|
urn:oid:1.2.36.1.2001.1005.17
|
Pertussis
|
|
|
PANVAX
|
urn:oid:1.2.36.1.2001.1005.17
|
Panvax
|
|
|
PDCL
|
urn:oid:1.2.36.1.2001.1005.17
|
Pediacel
|
|
|
PLCL
|
urn:oid:1.2.36.1.2001.1005.17
|
Poliacel
|
|
|
PNEUMO
|
urn:oid:1.2.36.1.2001.1005.17
|
Pneumovax
|
|
|
PRPD
|
urn:oid:1.2.36.1.2001.1005.17
|
ProHIBit
|
|
|
PROQAD
|
urn:oid:1.2.36.1.2001.1005.17
|
ProQuad
|
|
|
PRPOMP
|
urn:oid:1.2.36.1.2001.1005.17
|
PedvaxHIB
|
|
|
PRPT
|
urn:oid:1.2.36.1.2001.1005.17
|
ActHIB
|
|
|
PRVNR
|
urn:oid:1.2.36.1.2001.1005.17
|
Prevenar
7
|
|
|
PRVTH
|
urn:oid:1.2.36.1.2001.1005.17
|
Prevenar
13
|
|
|
PRXTEX
|
urn:oid:1.2.36.1.2001.1005.17
|
Priorix-Tetra
|
|
|
QDCL
|
urn:oid:1.2.36.1.2001.1005.17
|
Quadracel
|
|
|
ROTRIX
|
urn:oid:1.2.36.1.2001.1005.17
|
Rotarix
|
|
|
ROTTEQ
|
urn:oid:1.2.36.1.2001.1005.17
|
Rotateq
|
|
|
SYNFLX
|
urn:oid:1.2.36.1.2001.1005.17
|
Synflorix
|
|
|
TCL
|
urn:oid:1.2.36.1.2001.1005.17
|
Tripacel
|
|
|
VAXGRP
|
urn:oid:1.2.36.1.2001.1005.17
|
Vaxigrip
|
|
|
VGRJNR
|
urn:oid:1.2.36.1.2001.1005.17
|
Vaxigrip
Junior
|
|
|
VLRIX
|
urn:oid:1.2.36.1.2001.1005.17
|
Varilrix
|
|
|
VRVAX
|
urn:oid:1.2.36.1.2001.1005.17
|
Varivax
|
|